These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9270401)

  • 1. Torsades de pointes with terfenadine ingestion.
    June RA; Nasr I
    Am J Emerg Med; 1997 Sep; 15(5):542-3. PubMed ID: 9270401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsades de pointes occurring in association with terfenadine use.
    Monahan BP; Ferguson CL; Killeavy ES; Lloyd BK; Troy J; Cantilena LR
    JAMA; 1990 Dec; 264(21):2788-90. PubMed ID: 1977935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsades de pointes from terfenadine and sotalol given in combination.
    Feroze H; Suri R; Silverman DI
    Pacing Clin Electrophysiol; 1996 Oct; 19(10):1519-21. PubMed ID: 8904547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular toxicity of antihistamines.
    Smith SJ
    Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 2):348-54. PubMed ID: 7916150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.
    Takahara A; Sugiyama A; Ishida Y; Satoh Y; Wang K; Nakamura Y; Hashimoto K
    Br J Pharmacol; 2006 Mar; 147(6):634-41. PubMed ID: 16314854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsades de pointes complicating treatment with terfenadine.
    MacConnell TJ; Stanners AJ
    BMJ; 1991 Jun; 302(6790):1469. PubMed ID: 1676921
    [No Abstract]   [Full Text] [Related]  

  • 7. Torsades de pointes complicating treatment with terfenadine.
    Warin RP
    BMJ; 1991 Jul; 303(6793):58. PubMed ID: 1677597
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrocardiographic findings in patients with diphenhydramine overdose.
    Zareba W; Moss AJ; Rosero SZ; Hajj-Ali R; Konecki J; Andrews M
    Am J Cardiol; 1997 Nov; 80(9):1168-73. PubMed ID: 9359544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Torsades de pointes caused by cetirizine overdose].
    Renard S; Ostorero M; Yvorra S; Zerrouk Z; Bargas E; Bertocchio P; Pracchia S; Ebagosti A
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):157-61. PubMed ID: 15787309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health problems and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in The Netherlands.
    Herings RM; Stricker BH; Leufkens HG; Bakker A; Sturmans F; Urquhart J
    Pharm World Sci; 1993 Oct; 15(5):212-8. PubMed ID: 8257958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsades de pointes complicating treatment with terodiline.
    McLeod AA; Thorogood S; Barnett S
    BMJ; 1991 Jun; 302(6790):1469. PubMed ID: 1676922
    [No Abstract]   [Full Text] [Related]  

  • 12. Torsades de pointes associated with terfenadine in a case of liver cirrhosis and hepatocellular carcinoma.
    Kamisako T; Adachi Y; Nakagawa H; Yamamoto T
    Intern Med; 1995 Feb; 34(2):92-5. PubMed ID: 7727886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac actions of antihistamines.
    Woosley RL
    Annu Rev Pharmacol Toxicol; 1996; 36():233-52. PubMed ID: 8725389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog.
    Webster R; Allan G; Anto-Awuakye K; Harrison A; Kidd T; Leishman D; Phipps J; Walker D
    Xenobiotica; 2001; 31(8-9):633-50. PubMed ID: 11569530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia.
    Pohjola-Sintonen S; Viitasalo M; Toivonen L; Neuvonen P
    Eur J Clin Pharmacol; 1993; 45(2):191-3. PubMed ID: 8223844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terfenadine should be withdrawn from clinical use.
    Khilnani G
    J Assoc Physicians India; 1999 Sep; 47(9):943. PubMed ID: 10778682
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system.
    Ali Z; Ismail M; Khan F; Sajid H
    Expert Opin Drug Saf; 2021 Jan; 20(1):101-107. PubMed ID: 33141610
    [No Abstract]   [Full Text] [Related]  

  • 18. Torsades de pointes induced by nonantiarrhythmic drugs.
    Tran HT
    Conn Med; 1994 May; 58(5):291-5. PubMed ID: 7915666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation antihistamines: the risk of ventricular arrhythmias.
    DuBuske LM
    Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmias.
    Wynn RL
    Gen Dent; 1993; 41(1):27-9. PubMed ID: 7489857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.